Stockreport

Clear Street Initiates Buy on Dianthus Therapeutics, Inc. (DNTH) With $100 Price Target [Yahoo! Finance]

Dianthus Therapeutics, Inc.  (DNTH) 
PDF Therapeutics, Inc. (NASDAQ:DNTH) with a ‘Buy' rating and a price target of $100, implying a potential upside of nearly 172% from the current price. This optimism is driv [Read more]